Jun Lü
-
- Foot and Ankle Surgery 16
- Tendon Structure and Treatment 15
- Cancer Research top 10%
- Oncology top 10%
- Molecular Biology top 10%
- Cancer-related gene regulation 6
-
- Acute Lymphoblastic Leukemia research 13
-
- Gastric Cancer Management and Outcomes 11
-
- Mast cells and histamine 7
-
- Orthopedic Surgery and Rehabilitation 7
- Cholangiocarcinoma and Gallbladder Cancer Studies 6
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Jun Lü
150 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 126
- Orthopedics and Sports Medicine 178
- Cancer Research 255
- Oncology 384
- Molecular Biology 961
- Complementary and alternative medicine 101
Countries citing papers authored by Jun Lü
This map shows the geographic impact of Jun Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Lü more than expected).
Fields of papers citing papers by Jun Lü
This network shows the impact of papers produced by Jun Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Lü. The network helps show where Jun Lü may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jun Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 11 | |
| 4 | 2021 | 6 | |
| 5 | 2021 | 2 | |
| 6 | 2020 | 3 | |
| 7 | 2019 | 24 | |
| 8 | 2018 | 3 | |
| 9 | 2018 | 35 | |
| 10 | 2017 | 12 | |
| 11 | 2017 | 14 | |
| 12 | Immunogenic chemotherapy sensitizes non-small cell lung cancer to immune checkpoint blockade therapy in preclinical models | 2017 | 2 |
| 13 | 2017 | 62 | |
| 14 | 2017 | 5 | |
| 15 | 2017 | 43 | |
| 16 | 2016 | 33 | |
| 17 | miR-183 inhibits invasion of gastric cancer by targeting Ezrin. | 2014 | 33 |
| 18 | 2013 | 25 | |
| 19 | 2013 | 22 | |
| 20 | [Classical and molecular cytogenetic abnormalities in 124 pediatric patients with acute lymphoblastic leukemia]. | 2007 | 5 |
About Jun Lü
Jun Lü is a scholar working on Orthopedics and Sports Medicine, Transplantation, Oncology, Hematology and Cancer Research, having authored 156 papers that have together received 2.6k indexed citations. Recurring topics across this work include Foot and Ankle Surgery (16 papers), Tendon Structure and Treatment (15 papers), Acute Lymphoblastic Leukemia research (13 papers), Gastric Cancer Management and Outcomes (11 papers), Mast cells and histamine (7 papers), Orthopedic Surgery and Rehabilitation (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Cancer-related gene regulation (6 papers). The work is most often cited by research in Orthopedics and Sports Medicine (178 citations), Cancer Research (255 citations), Oncology (384 citations), Molecular Biology (961 citations) and Complementary and alternative medicine (101 citations). Jun Lü has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yalin Dong, Linnea M. Baudhuin, Hairong He, Jianfeng Xing, Sasa Hu, Yan Xu, Jiangxia Cai, Jiawen Yu, Siying Chen and Changquan Zhang. Their work appears in journals such as Journal of Cancer, OncoTargets and Therapy, Medicine, International Journal of Molecular Sciences and The Journal of Foot & Ankle Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.